Search clinical trials for: Ofatumumab placebo
Total 53755 results
-
GlaxoSmithKlineCompletedMultiple SclerosisUnited States, Bulgaria, Russian Federation, Spain, Germany, Czechia, Netherlands, Norway, Italy, Canada, Denmark
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineTerminatedArthritis, RheumatoidPoland, Russian Federation, Argentina, Belgium, Peru, Spain, Australia, Czechia, South Africa, Chile, Hungary, United Kingdom, Romania
-
GlaxoSmithKlineCompletedArthritis, RheumatoidRussian Federation, Australia, Belgium, Spain, United States, New Zealand, Italy, Poland, France
-
GlaxoSmithKlineTerminatedArthritis, RheumatoidUnited States, Denmark, Hungary, United Kingdom, Poland
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, Chronic and Lymphoma, FollicularJapan
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, Chronic
-
Novartis PharmaceuticalsCompleted
-
Fondazione Italiana Linfomi ONLUSCompletedFollicular Lymphoma, Grade 1 | Follicular Lymphoma, Grade 2 | Follicular Lymphoma Grade 3AItaly
-
Novartis PharmaceuticalsTerminatedPemphigus VulgarisUnited States, Australia, Greece, Israel, Italy, Japan, Poland, Romania
-
Novartis PharmaceuticalsRecruitingMultiple Sclerosis (MS)France
-
Gruppo Italiano Malattie EMatologiche dell'AdultoActive, not recruitingLeukemia, Lymphoblastic, ChronicItaly
-
Massachusetts General HospitalGlaxoSmithKline; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical...CompletedFollicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic LymphomaUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedRelapsed or Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Austria, Belgium, France, Ireland, Italy, Poland, Spain, United Kingdom
-
Michael John RobertsonNovartisCompletedNon-Hodgkin's LymphomaUnited States
-
Novartis PharmaceuticalsCompletedRelapsing Multiple SclerosisJapan, Russian Federation
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisAustralia
-
Novartis PharmaceuticalsRecruiting
-
Joseph TuscanoGlaxoSmithKlineCompletedChronic Lymphocytic LeukemiaUnited States
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, ChronicKorea, Republic of, Japan
-
Pharmacyclics LLC.Ohio State UniversityCompletedB-cell Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Richter's Transformation | Prolymphocyctic LeukemiaUnited States
-
GlaxoSmithKlineTerminatedArthritis, RheumatoidItaly, Argentina, Germany, Peru, Korea, Republic of, Denmark, Spain, Sweden, France, Netherlands, Norway, United Kingdom
-
University Health Network, TorontoNovartisCompletedChronic Lymphocytic Leukemia (CLL)Canada
-
Novartis PharmaceuticalsCompletedMultiple SclerosisUnited States, Austria, Spain, Czechia, Estonia, Bulgaria, Latvia, Lithuania, Russian Federation
-
Brown UniversityThe Miriam Hospital; Dartmouth-Hitchcock Medical Center; Rhode Island Hospital; Memorial Hospital of Rhode IslandTerminatedLymphoma, Non-HodgkinsUnited States
-
GlaxoSmithKlineCompleted
-
Novartis PharmaceuticalsCompletedRelapsing Multiple ScelrosisUnited States, Austria, Belgium, Croatia, Germany, Taiwan, Canada, Czechia, Spain, Argentina, Australia, Peru, South Africa, United Kingdom, Bulgaria, Latvia, Lithuania, Russian Federation, India, Portugal, Italy, Turkey, Finland, France and more
-
Novartis PharmaceuticalsCompletedRelapsing Multiple SclerosisBelgium, Italy, United States, Croatia, Spain, Netherlands, Switzerland, Thailand, Israel, Czechia, Estonia, Poland, France, Bulgaria, Russian Federation, Germany, Turkey, Slovakia, Australia, Denmark, Greece, Argentina, India, Hungary, United Kingdom and more
-
Januario Castro, M.D.GlaxoSmithKlineCompleted
-
Nevada Cancer InstituteGlaxoSmithKline; CephalonWithdrawnChronic Lymphocytic Leukemia (CLL)United States
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedChronic Graft Versus Host DiseaseUnited States
-
University of CologneCompleted
-
GlaxoSmithKlineCompletedLymphoma, Large-Cell, DiffuseUnited Kingdom
-
GlaxoSmithKlineCompletedWaldenstrom MacroglobulinaemiaUnited States
-
Novartis PharmaceuticalsCompleted
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); GlaxoSmithKlineTerminatedWaldenström MacroglobulinemiaUnited States
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineCompletedMantle Cell LymphomaUnited States
-
Nevada Cancer InstituteGlaxoSmithKline; CephalonTerminatedChronic Lymphocytic Leukemia (CLL)United States
-
Novartis PharmaceuticalsRecruiting
-
M.D. Anderson Cancer CenterGlaxoSmithKlineCompletedChronic Lymphocytic LeukemiaUnited States
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
SCRI Development Innovations, LLCGlaxoSmithKlineCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Grupo Español de Linfomas y Transplante Autólogo...Completed
-
Oncology Specialists, S.C.University of Illinois at ChicagoTerminatedNon-Hodgkin LymphomasUnited States
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, Chronic
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, ChronicUnited States, United Kingdom
-
M.D. Anderson Cancer CenterGlaxoSmithKlineActive, not recruitingLymphoma | LeukemiaUnited States
-
SCRI Development Innovations, LLCGlaxoSmithKline; NovartisCompletedChronic Lymphocytic LeukemiaUnited States